Early glottic cancer treatment with concurrent chemoradiotherapy with once-daily orally administered S-1

Glottic carcinoma is the most common laryngeal cancer. The outcomes for T1 bulky Glottic carcinoma and T2N0 Glottic carcinoma after radiation therapy alone are unsatisfactory. This study was conducted to evaluate the efficacy and safety of unique concurrent chemoradiotherapy regimen using S-1 for ea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nagoya J Med Sci
Autors principals: Takase, Yuuki, Itoh, Yoshiyuki, Ohtakara, Kazuhiro, Kawamura, Mariko, Ito, Junji, Oie, Yumi, Ono, Tamami, Sasaki, Yutaro, Nishida, Ayumi, Naganawa, Shinji
Format: Artigo
Idioma:Inglês
Publicat: Nagoya University 2021
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8236680/
https://ncbi.nlm.nih.gov/pubmed/34239173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18999/nagjms.83.2.251
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars